Prostate Cancer Reports



Volume 3 Number 3
March 2015

Home > Prostate Cancer Reports > Volume 3, Year 2015 > Number 3, March

CONTENTS


Detection, diagnosis and evaluation
Prognosis and outcome
Quality of life
Treatment


DETECTION, DIAGNOSIS AND EVALUATION



Kerr BA, Miocinovic R, Smith AK, West XZ, Watts KE, Alzayed AW, Klink JC, Mir MC, Sturey T, Hansel DE, Heston WD, Stephenson AJ, Klein EA, Byzova TV.
CD117⁺ cells in the circulation are predictive of advanced prostate cancer.
Oncotarget. 2015 Jan 30;6(3):1889-97.
Abstract | Full text | Similar articles

PROGNOSIS AND OUTCOME



Pietzak EJ 3rd, Kabarriti AE, Mucksavage P, Bavaria T, Van Arsdalen K, Malkowicz SB, Wein AJ, Guzzo TJ.
The presence of high-grade prostatic intraepithelial neoplasia or atypia on prostate biopsy does not adversely affect prostatectomy outcomes for patients otherwise eligible for active surveillance.
Urology. 2014 Dec;84(6):1442-7. doi: 10.1016/j.urology.2014.04.066. Epub 2014 Oct 5.
Abstract | Similar articles

QUALITY OF LIFE



Drummond FJ, Kinnear H, O'Leary E, Donnelly, Gavin A, Sharp L.
Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study.
J Cancer Surviv. 2015 Jun;9(2):361-72. doi: 10.1007/s11764-014-0419-6. Epub 2015 Jan 7.
Abstract | Similar articles


Kim JH, Lee SW.
Current status of penile rehabilitation after radical prostatectomy.
Korean J Urol. 2015 Feb;56(2):99-108. doi: 10.4111/kju.2015.56.2.99. Epub 2015 Jan 30.
Abstract | Full text | Similar articles

TREATMENT



Katayama S, Striecker T, Kessel K, Sterzing F, Habl G, Edler L, Debus J, Herfarth K.
Hypofractionated IMRT of the prostate bed after radical prostatectomy: acute toxicity in the PRIAMOS-1 trial.
Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):926-33. doi: 10.1016/j.ijrobp.2014.07.015. Epub 2014 Sep 9.
Abstract | Similar articles


Pontoriero A, Iatý G, Mondello S, Midili F, Siragusa C, Brogna A, Ielo I, Anastasi G, Magno C, Pergolizzi S, De Renzis C.
High-Dose Robotic Stereotactic Body Radiotherapy in the Treatment of Patients With Prostate Cancer: Preliminary Results in 26 Patients.
Technol Cancer Res Treat. 2015 Jan 13. pii: 1533034614566994. [Epub ahead of print]
Abstract | Similar articles


Surapaneni A, Schwartz D, Nwokedi E, Rineer J, Rotman M, Schreiber D.
Radiation therapy for clinically localized prostate cancer: Long-term results of 469 patients from a single institution in the era of dose escalation.
J Cancer Res Ther. 2014 Oct-Dec;10(4):951-6. doi: 10.4103/0973-1482.138096.
Abstract | Full text | Similar articles


Vlachostergios PJ, Papandreou CN.
Targeting neuroendocrine prostate cancer: molecular and clinical perspectives.
Front Oncol. 2015 Feb 2;5:6. doi: 10.3389/fonc.2015.00006. eCollection 2015.
Abstract | Full text | Similar articles


Xia X, Mai J, Xu R, Perez JE, Guevara ML, Shen Q, Mu C, Tung HY, Corry DB, Evans SE, Liu X, Ferrari M, Zhang Z, Li XC, Wang RF, Shen H.
Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response.
Cell Rep. 2015 May 12;11(6):957-66. doi: 10.1016/j.celrep.2015.04.009. Epub 2015 Apr 30.
Abstract | Full text | Related citations | News